Healthcare IT firm Aspyra of Westlake Village, CA, has given notice to the NYSE Amex stock exchange that it will voluntarily delist its common stock from the exchange and deregister its common stock under the Securities Exchange Act.
The firm's board of directors made the decision for a number of reasons, including the value that the public markets are currently applying to the stock and costs associated with preparation and filing of reports with the Securities and Exchange Commission. In addition, the board judged that many of the usual advantages of being a public company, such as enhanced access to capital, are not sufficiently available to justify related costs at this time.
The company reports it has not made any arrangements to have its common stock listed on any other exchange.
Related Reading
Aspyra launches CyberLab upgrade, October 14, 2009
Aspyra takes California order, September 22, 2009
Aspyra nets Oklahoma contract, August 7, 2009
Aspyra launches AccessRad upgrade, June 4, 2009
Aspyra wins New York contract, April 28, 2009
Copyright © 2009 AuntMinnie.com